Although there is no evidence of the impact of this sequence variant on prostate cancer risk among European and African American men, the relationship between the IL1R2 gene expression and prostate cancer has been demonstrated through published reports[27-29]. The gene discussed is IL1R2; the disease is prostate carcinoma.